Cardiac resynchronization therapy with defibrillator (CRT-D) has demonstrated reduced mortality and heart failure (HF) hospitalizations in patients with left ventricular dysfunction. Prior studies have suggested that women may benefit more… Click to show full abstract
Cardiac resynchronization therapy with defibrillator (CRT-D) has demonstrated reduced mortality and heart failure (HF) hospitalizations in patients with left ventricular dysfunction. Prior studies have suggested that women may benefit more than men from CRT-D. Using a post hoc analysis of the
               
Click one of the above tabs to view related content.